Editorials
Incretins and cancer of the bile duct in type 2 diabetes
BMJ 2018; 363 doi: https://doi.org/10.1136/bmj.k5155 (Published 06 December 2018) Cite this as: BMJ 2018;363:k5155Linked research
Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes